1.
Cell Mol Biol (Noisy-le-grand)
; 55(2): 147-51, 2009 Jul 01.
Article
in English
| MEDLINE
| ID: mdl-19656463
ABSTRACT
Acute porphyrias are caused by enzyme defects along the heme synthesis pathway. Patients usually present with abdominal pain, impaired intestinal motility, neurological and psychiatric symptoms, hypertension, tachycardia, hyponatriemia and reddish urine. This article gives an overview over drugs that are recommended in patients with acute hepatic porphyrias and represents a compilation of four so far existing lists.
Subject(s)
Drug-Related Side Effects and Adverse Reactions , Porphyria, Acute Intermittent/therapy , 5-Aminolevulinate Synthetase/antagonists & inhibitors , 5-Aminolevulinate Synthetase/metabolism , Arginine/therapeutic use , Heme/metabolism , Heme/therapeutic use , Humans , Liver Transplantation
2.
Anat Rec
; 243(2): 186-94, 1995 Oct.
Article
in English
| MEDLINE
| ID: mdl-8554174